<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01813760</url>
  </required_header>
  <id_info>
    <org_study_id>CYN12-AFF-UL-09</org_study_id>
    <nct_id>NCT01813760</nct_id>
  </id_info>
  <brief_title>Treatment of Periorbital and Perioral Wrinkles With the Applications of the Iluminage Diode Laser</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cynosure, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cynosure, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Diode laser system is being used in this marketing study for the treatment of wrinkles
      around the eyes and mouth.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">August 2013</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Photographic Evaluation</measure>
    <time_frame>60 days post first treatment</time_frame>
    <description>Compare severity of wrinkles from baseline to 60 days post treatment based on Fitpatrick Scale.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Adverse Events</measure>
    <time_frame>up to 4 months post 1st treatment</time_frame>
    <description>Adverse events and side effects will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Photographic Evaluation</measure>
    <time_frame>Up to 40 days</time_frame>
    <description>Compare severity of wrinkles from baseline to 1,10, 20 and 40 days post treatment based on Fitzpatrick Scale.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Peri-orbital Wrinkles</condition>
  <condition>Peri-oral Wrinkles</condition>
  <arm_group>
    <arm_group_label>Diode laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Diode laser to treat peri-orbital and peri-oral wrinkles</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Illuiminage ® Diode Laser</intervention_name>
    <description>Diode laser for treatment of peri-orbital and peri-oral wrinkles</description>
    <arm_group_label>Diode laser</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subjects who are healthy females between 35 and 60 years of age.

          2. Subjects who have Fitzpatrick skin type I-VI

          3. Subjects who have provided written and verbal informed consent

          4. Subjects who are willing and able to comply with study instructions and to return to
             the clinic for required visits and have photographs of their face taken

          5. Subjects who have perioral and periorbital wrinkles, as deemed appropriate by the
             Investigator or his designees

        Exclusion Criteria:

          1. Subjects who currently use or have used in the prior 30 days any skin products that
             contain alpha hydroxy acids (AHA) e.g. glycolic, lactic, citric, or mendelic acid
             containing products or retinol/tretinoin containing products or exfoliating washes,
             masks or scrubs or other micro-dermabrasion skin care products. on the laser
             application areas

          2. Subjects who are unwilling to maintain their daily skin care regimen for the duration
             of the study,

          3. Subjects who have any skin pathology or condition that could interfere with the
             evaluation i.e. personal or family history of skin cancer, rosacea and/or requires the
             use of interfering topical or systemic therapies.

          4. Subjects with synthetic or metal implants or permanent cosmetic tattoos in the test
             areas

          5. Subjects who have a history of abnormal scarring, e.g. keloids or have significant
             scarring in the areas to be treated

          6. Subjects with bleeding disorders or taking anticoagulation medications, including
             heavy use of aspirin

          7. Subjects who have participated in any clinical investigation involving the face within
             the 30 days prior to the first planned laser application or subjects who plan to
             participate in concomitant facial studies during this trial

          8. Subjects, who are pregnant, were pregnant or gave birth in the last 3 months, are
             currently breast feeding, or might become pregnant during the course of the study

          9. Subjects who have a history of light triggered seizures

         10. Subjects with prior use of neurotoxins e.g. Botox®, collagen, fat injections and/or
             other methods of skin augmentation (enhancement with injected or implanted material)
             of the face or having had chemical peels within 6 months of initial laser application
             or planning to so during the course of the study

         11. Subject's use of oral isotretinoin (Accutane®) within 12 months of initial laser
             application or during the course of the study

         12. Subjects having had facial skin treatments with any professional laser, light based,
             radiofrequency or other devices within the last year

         13. Subjects ever having facial skin treatments with home use laser, light based or
             radiofrequency or other devices, i.e. PaloVia® or Tria®
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patricia Krantz</last_name>
    <role>Study Director</role>
    <affiliation>Cynosure, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cynosure, Inc</name>
      <address>
        <city>Westford</city>
        <state>Massachusetts</state>
        <zip>01886</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2013</study_first_submitted>
  <study_first_submitted_qc>March 15, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2013</study_first_posted>
  <last_update_submitted>March 25, 2014</last_update_submitted>
  <last_update_submitted_qc>March 25, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

